10--Notice of Intent Award for a Chondrocytes cell & Implantation system

The U.S. Army Medical Command, Western Regional Contracting Office in Tacoma, Washington, plans to award a firm-fixed price contract valued at $35,000 to US Bioservices for the acquisition of a Chondrocytes cell and Implantation system. This decision aligns with the determination made by a surgeon, concluding that these specific products best meet the medical requirements for a particular patient. All products under this contract must have FDA approval and adhere strictly to the specified medical needs of both surgeon and patient. The procurement will be executed following simplified acquisition procedures as outlined in FAR Part 13, specifically FAR Subpart 13.106-1(b)(1). Although no solicitation will be issued through this notice, firms interested in supplying similar products in the future are invited to demonstrate their capabilities by submitting supporting documentation on their products’ specifications. This information will aid future acquisitions rather than serve as an immediate request for proposal. Interested parties should direct their responses via email to the designated Purchasing Agent, Ms. Jenni Lundquist, with no telephone or fax communications accepted. This approach ensures compliance with federal acquisition regulations while providing transparency and opportunities for other potential suppliers in upcoming contracts.